Good morning, everyone, and thank you for joining us for Mativ's fourth quarter and full year 2023 earnings call. Before we begin, I'd like to remind you that comments included in today's conference call include forward-looking statements. Actual results may differ materially from these comments for reasons shown in detail in our Securities and Exchange Commission filings, including our annual report on Form 10-K and our quarterly reports on Form 10-Q. Some of the financial measures discussed during this call are non-GAAP financial measures. Reconciliations of these measures to the closest GAAP measures are included in the appendix of the earnings release and accompanying presentation slides. Unless stated otherwise, financial and operational metric comparisons are to the prior-year period and relate to continuing operations. The earnings release issued yesterday afternoon is available on our website at ir.mativ.com as are the slides for today's presentation. You can download the slides and/or click through these slides at your own pace during the call using the webcast interface. Since the SWM and Neenah merger closed on July 6th, 2022, the third and fourth quarters of 2023 are the first reporting periods since the merger that are truly comparable. However, year-to-date GAAP results for the first half of 2022 will still only include legacy SWM. So, this was prior to the merger. Comparable performance for year-to-date figures to illustrate how our results compare on a like-for-like basis are shown in tables in our earnings release and the appendix of our presentation slides. Finally, with the November close of the sale of the engineered papers, results for this business are now being summarized separately as discontinued operations with all remaining businesses being reported as continuing operations. With that, I'll turn the call over to Julie.

Thank you, Chris. Good morning everyone, and thank you for joining our call. Greg and I have a lot of topics to cover with you today. In addition to our quarterly and full-year financial results, an update on our operating environment and our thoughts on the path ahead in 2024, we also want to share more details about our restructuring and overhead cost reduction initiatives that we announced in late January of this year. This effort will streamline our organizational size, shape, and complexity, simplify reporting lines, and amplify the way we leverage our business-critical resources to enhance how we serve and support our customers. I'm excited to share the details of this comprehensive plan with you and the broader investment community as I believe it represents a step change in how we run our business and will accelerate our path to growth ahead. Let's start with our Q4 and full-year 2023 results. Sales from continuing operations were $452 million for the quarter, down 14% year over year, and $2 billion for the full year, down 9% on a comparable basis. This performance mainly reflects continued lower volumes due to the challenging macroeconomic environment caused by an industry-wide destocking trend, geopolitical adversity, and high-interest rates impacting our end markets. We believe that the overall destocking trend, which has persisted for over a year, is at or near the bottom, and we have a line of sight to positive signs of demand momentum in many of our end markets. We are encouraged by these early indicators and look forward to the opportunities that lie ahead. Adjusted EBITDA was $50 million for the quarter down 20% year over year, and $213 million for the full year down 17% on a comparable basis. The biggest driver of this continues to be low volume as it impacts fixed cost absorption and reduces the realization of our implemented pricing actions and merger synergies. We combat this trend through a relentless focus on continuous operational improvement and cost minimization throughout the manufacturing process and broader supply chain, as well as consistent and disciplined price management. Especially in this low-demand environment, we are laser-focused on implementing these actions to deliver immediate and lasting results. We also expect to realize increased operating leverage when our demand profile improves. You can see the impact of these efforts in both segments, ability to drive tangible adjusted EBITDA margin improvement quarter over quarter. This quarter also marked the finish of our first full fiscal year as Mativ. A year and a half ago, we set out to combine two separate successful legacy companies into a more powerful and focused specialty materials leader. Today, we look back at an eventful 18 months. That included many accomplishments and milestones against a backdrop of a very challenged macro environment. We started 2023 by setting our enterprise ambition, defining our operating model, and benefiting from the results of early SG&A synergies during our initial integration period. This allowed us to press forward to streamline our business operations and procurement activities to deliver on our synergy potential. We began the year with a goal of $25 million in realized synergies in 2023, and I'm pleased to share that we achieved this goal at a faster pace than initially expected, realizing over $30 million in synergies in the year, and that our journey to achieve our total of $65 million in synergies is ahead of schedule. Most of the remaining synergies are focused on efficiencies within our procurement and supply chain areas, and we expect to capture these savings quickly and efficiently over the next 18 months. In November, we closed on the sale of our engineered papers business to a Singapore-based Evergreen Hill Enterprise. The sale of engineered papers was the culmination of a strategic initiative that began after the merger to focus our portfolio on our fastest growing end markets. I'm very pleased with the outcome of this transaction, as I believe we were able to find a great partner for engineered papers while significantly enhancing our portfolio mix. Furthermore, the transaction aligned with our commitment to prioritize debt reduction. Net proceeds realized from the engineered paper sale were in excess of our initial projections and were used to reduce our outstanding debt balance by more than $600 million or approximately 35%. At the same time, we took a hard look at our capital allocation priorities and decided to further support debt reduction. We reduced our dividend effective September 2023, committed to a share buyback program intended to counter dilution, and right-sized our capital spending plans by more than 10%. In support of our strategy of focused investments to accelerate growth, we announced and are in the process of starting up new assets in our filtration and release liners business. These are two of our identified growth platforms where we provide unique solutions to meet our customers' most challenging needs. Our new filtration melt-blown line will start up in Germany in Q1 2024, and we added a silicone release coder in Mexico to target growth in North and South America in fast-growing applications such as labels, adult care, and composites. This new coder in Mexico has started up and is running trials for customer qualifications, performing in line with our investment thesis. Combined, these investments will support $50 million of revenue growth as they ramp up, qualify, and become fully utilized. Also, as expected, we are continuing to consolidate our asset and warehouse footprint. We are currently in the process of streamlining our operations through the consolidation of three less profitable manufacturing sites into larger, more scalable facilities. Among those efforts was the sale of a small facility in the UK and announced closure of a plant and the consolidation of another small facility both in the U.S. We are also actively streamlining our warehousing and distribution network. For example, we've reduced the number of warehouses by about 10% since the merger and plan to reduce this number by another 10% by the end of this year. Taken together, these long-term decisions will drive benefits in reducing costs, improving the customer experience, and driving margin performance, especially as demand returns to more normalized levels. With that, I'll turn it over to Greg for a more detailed discussion of our financial performance and then I'll provide some color on our new structure and Mativ going forward.

Thanks, Julie, and good morning everyone. Consolidated net sales for the quarter were $452 million compared to $524 million in the prior year, with volume down 14% partially offset by favorable currency. Adjusted EBITDA from continuing operations was $50 million down from $62 million in the prior year. Volume presented a $31 million impact, which was only partially offset by combined net selling price, input cost benefits, and favorable impacts from a lower SG&A, realized synergies, and currency. Turning to each of our legacy segments, net sales in advanced technical materials of $362 million were down 12% year over year. This reflected lower volumes due to continued customer caution in the uncertain macroeconomic environment, as well as high-interest rates that impact our end markets. ATM adjusted EBITDA of $56 million was down 9% year over year, reflecting the effects of lower volumes that were partially offset by a positive net selling price, input cost distribution efficiencies, and currency translation. Despite weak demand, we improved the adjusted EBITDA margin by 30 basis points year over year and 50 basis points sequentially mainly due to realized synergies. In our fiber-based solutions segment, comprised solely of packaging and specialty papers, net sales of $90 million were down 22% from last year and in line with the broader market. Year-over-year results reflected customer destocking along with suppressed demand for premium paper and packaging. FBS adjusted EBITDA of $13 million was down 35% year over year. Lower volume and associated manufacturing cost impacts in the current quarter were partially offset by favorable net selling price and input cost. Turning to a few of the corporate items, unallocated corporate adjusted EBITDA expenses of around $19 million were flat year over year and interest expense of $13 million was also essentially flat from the prior period. Other expense was down $3 million from 2022 when we recorded gains on foreign currency contracts. Our tax was a 19% benefit in the quarter. Julie referenced the successful November close of our engineered papers business and the subsequent pay down of more than $600 million in net debt, and I'd like to add that while we initially expected net proceeds to be around $575 million when we announced the transaction in August, we actually applied $632 million to debt reduction, for more than 35% of our total debt. As expected, we also reduced net leverage sequentially by 0.3 turns to 3.9 times credit agreement EBITDA. At the end of the quarter, our remaining net debt was just under $1 billion and available liquidity was $454 million. As a reminder, our debt matures on a staggered basis between 2026 and 2028. We also repurchased just under $4 million of shares in the quarter. Our intent continues to be to opportunistically repurchase shares to offset dilution from stock compensation, and to be clear, the priority of cash flow remains paying down debt. While at this point we are not providing 2024 guidance, let me provide some color on a few assumptions that underlie our 2024 financial plans. For Q1 of 2024, while we expect a significant sequential step-up in sales due to the higher cost of inventory that will sell through in Q1, we expect adjusted EBITDA to be similar to Q4. We expect Q1 will still be impacted by the current demand pace, but we continue to get insights from customers that provide confidence in an elevated demand pace in Q2 of 2024. We are maintaining our expectation of sequential quarterly improvements subject to our normal year-end seasonality, building toward a $70 million run rate at year end, and our previously announced overhead reduction program yielding a $20 million annualized savings run rate by the end of 2024, further solidifies this increased EBITDA level. For modeling purposes, going forward, we expect our annual interest expense to be around $70 million and our depreciation and amortization expense should be around $100 million annually. With that, Julie, I'll turn it back to you to talk about a recent announcement and matter of going forward.

Thanks, Greg. There's no question that the environment in 2023 was not what we expected, and our results are not representative of our future expectations. As we saw demand continue to weaken, we focused on those areas that we could control and made several meaningful and impactful decisions throughout the year. Many of those decisions were difficult but necessary, as they paved the path for a more successful enterprise that will drive both growth and margin results. Since the merger, we've established our company strategy, defined our operating model, streamlined our operations, and achieved above-targeted synergy levels. We also right-sized our portfolio and oriented it towards stronger end markets that will support our growth in top line and bottom line going forward. With the sale of engineered papers and with a lot of integration efforts behind us or in process, now is the right time to streamline our administrative functions in support of a more focused and less complex organization. As part of this initiative, we've announced two discrete waves of cost reduction efforts focused on non-operating costs. The first wave is currently underway and consists mainly of workforce reductions that are indexed towards senior levels of the organization and will have an impact on our P&L this year. We expect to achieve a run rate of $20 million in overhead cost savings by the end of 2024. The associated expenses are expected to be in the $15 million to $20 million range, comprised mainly of severance costs and will hit the P&L predominantly in the first half of 2024. The second wave of cost reduction efforts is driven primarily by system integration. This work will improve transactional efficiencies and further reduce head count, but with longer implementation timelines. With the second effort, we expect to achieve an additional $20 million in overhead cost savings by the end of 2026. Taken together, both waves will reduce overall non-operating costs by approximately 15% over this timeframe. As part of these initiatives, we are realigning our operations into two new segments, ultimately simplifying reporting lines and reducing operational complexity. Our filtration and advanced material segment will be focused on filtration and protective coating and film solutions, serving customers that depend on us to make air and water cleaner, optical films sharper, and surfaces more scratch-resistant. This segment is driven by macro factors such as the increased need for clean air, access to clean water, high-performance protection features that, for example, safeguard products from sunlight, sound, water, and temperature, as well as support the movement to alternative energy sources and infrastructure development. Our highly engineered materials and our advanced technologies make us an unmatched and clear choice for our customers to support these megatrends. We consider this segment on a comparative basis to be our higher growth and higher margin segment. It will represent about 40% of our sales going forward, and we expect it to grow at GVP-plus rates with normalized EBITDA margins in the mid to high teens. This segment will be led by Christophe Stenzel, who has a long and successful track record at Mativ, leading our filtration segment to consistent growth over the last several years. Our sustainable and adhesive solution segment will be focused primarily on release liners, industrial products such as tapes, construction and cable wrap, healthcare, and packaging and specialty paper markets. This segment provides solutions that heal wounds faster, make packaging more sustainable, and ensure paint and DIY projects exceed expectations. It will be driven by macro factors such as adhesive use in permanent and temporary connections, sustainability, and eco-friendly alternatives. Personal health and wellness, particularly for an aging population as well as new construction and remodeling. This segment will comprise about 60% of our sales, and we expect to grow relatively in line with long-term broad economic growth in the US and Europe, and to a smaller degree, Asia. Normalized EBITDA margin for this segment is expected to be in the low to mid-teens. This segment will be led by Ryan Elwart, who recently joined us from Georgia Pacific, where he was Chief Customer Officer with a strong track record of fostering long mutually beneficial customer relationships. I'm excited to welcome Ryan to Mativ, and I've personally worked with him before and can attest that he embodies our win with customers' core value. This segment realignment has already gone into effect in Q1 2024 and will reduce our organizational complexity, drive substantial cost savings, provide further cross-selling opportunities, and allow us to better leverage technologies, marketing, and R&D. If you look at our journey over the last 18 months, you will realize how much Mativ has evolved in this short period of time. We've transformed Mativ from two legacy companies to a more agile and focused enterprise. We've proven our ability to navigate some of the toughest demand and macro environment challenges while integrating our teams and businesses. We've made bold decisions on our portfolio, our assets, and cost structure and taken action to unlock value that will be further amplified when demand picks up. I'm encouraged by our position as we enter 2024, and look forward to realizing our remaining synergies as well as our incremental cost savings described earlier today. But most of all, I'm encouraged by the early signs of momentum we're seeing in our demand profile as we enter 2024. We are well positioned to take advantage of returning demand, and I'm excited about our second full year as Mativ and demonstrating the results of these decisions and actions. Thank you for joining us this morning, and please open the line for questions.

Thank you, good morning, Julie, Greg, and Chris, thank you so much for all the details on that call and congrats on finishing the first year as a merged company. On the third quarter call, Julie, you mentioned just the issue with demand generation and how that was affecting obviously company performance. Could you provide us a little bit of an update on what you're doing to generate that demand and how you see that plan out thus far into 2024? And then maybe just more generally, what's the shape of demand? You referenced a little bit with some customer conversations, but what's the shape of demand thus far into the year and how do you see that playing out? Referencing seasonality or whatever else may be going on.

Sure. Thanks for the question, Dan. As we enter Q1, we're seeing signs of improved demand in some key areas and end markets in the early days. From a shape standpoint, we expect significant sequential revenue increases in Q1, and as we work through the year with a little bit more normal seasonality as we end the year in Q4. As Greg mentioned, the bottom line results will take an extra quarter to catch up just because of the high cost inventory and the flow through in Q1. But I'm encouraged by our demand picture, where we sit today and there's some key efforts the team is driving. I'd say R&D and innovation is one of those key efforts. The second one is customer programming and alignment with core customers. And then the third one is we've altered how we incent some of our teams from a revenue generation standpoint, and we've added capabilities and resources in some of those areas as well. So, we've really focused on how do we make sure our customer-facing resources are best leveraged. And that goes into some of the reorganization that we've talked about as well, being able to leverage resources broadly across marketing, sales, and R&D and prioritize where we have the greatest opportunities in those areas.

Great. That's super helpful, thank you. And just one more quick one if I may. Julie, last quarter you referenced kind of some bright spots being healthcare and hygiene, and then struggling in markets and construction and transportation. Is that still playing out kind of how you referenced last quarter or have there been some changes in terms of where you may be seeing some bright spots of demand?

I think it's starting to turn a bit, as I said Q1, we're seeing some bright spots and that's inclusive of our filtration business where we have transportation end markets, as well as life science end markets and clean air and water. It's inclusive of our release liner business that is driven by health and hygiene and labels and composites. Where it's probably still softest is in some of our commercial print markets. We're seeing that broadly and in the market data, but we're seeing nice demand improvement in Q1. I'm really pleased with the order profile that we have on board today.

Can we spend a couple minutes on the lower interest expense in the quarter and what kind of drove that? And I know you gave the full-year kind of number, but what is the kind of expected run rate going forward after paying down debt and resetting your interest rate swaps with the proceeds?

So overall, our expectation is that we would be around $70 million in interest for next year. So that would be a pace of about 17 or 18 a quarter. This quarter, you're right, we actually were at $13 million. It would've been about 17 to 18. But ultimately, we had a true-up related to the higher price that we received for the EP transaction. With that true-up and the movement between discontinued ops and continuing ops, it actually knocked that down to $13 million for the quarter. But ongoing, we'd expect normally in that 17 to 18 million a quarter. I'll maybe start there and then Julie, you can jump in. It's been encouraging the backlog reports that we have across several of our businesses. Of course, we continue to experience pressure and see that come down. Julie mentioned the trough that we've hit in Q4. We're seeing that in the backlog of orders now that is starting to build back. It's not roaring back, but we are actually seeing those build in several different areas, even in packaging and specialty papers. Julie just mentioned still the pressure on commercial print there, but we are seeing the backlog start to build some in packaging and specialty papers. Also, in our industrials business, which was one of the first ones to start to experience the destocking all the way back in late 2022. We're seeing an increase in the backlog of orders there as well.

Yes, just want to say thank you for joining the call today and for your support of Mativ, and we look forward to our next call next quarter.

Ladies and gentlemen, this concludes today's call. Thank you for joining. You may now disconnect your lines.